Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name SNHG16
   Synonyms SNHG16, Nbla10727, Nbla12061, ncRAN
   Region GRCh38_17:76557766-76565348    Sequence
   Ensembl ENSG00000163597
   RefSeq NR_038108
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name colorectal cancer
   ICD-0-3 C19.9  
   Methods RNA-seq, microarray, qPCR, RNAi etc.
   Sample CRC tissues, cell line (HCT116)
   Expression Pattern up-regulated
   Function Description

SNHG16 is significantly up-regulated in adenomas and all stages of CRC. SNHG16 expression was positively correlated to the expression of Wnt-regulated transcription factors, including ASCL2, ETS2, and c-Myc. In vitro abrogation of Wnt signaling in CRC cells reduced the expression of SNHG16 indicating that SNHG16 is regulated by the Wnt pathway. Silencing of SNHG16 resulted in reduced viability, increased apoptotic cell death and impaired cell migration. The SNHG16 silencing particularly affected expression of genes involved in lipid metabolism. A connection between SNHG16 and genes involved in lipid metabolism was also observed in clinical tumors.

   Pubmed ID 27396952
   Year 2016
   Title SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism.
   External Links
   Links for  SNHG16 GenBank       HGNC       lncrnadb       Noncode
   Links for  colorectal cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.